{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,29]],"date-time":"2026-10-29T13:44:23Z","timestamp":1793281463941,"version":"4.5.0"},"reference-count":97,"publisher":"Springer Science and Business Media LLC","issue":"12","license":[{"start":{"date-parts":[[2019,6,16]],"date-time":"2019-06-16T00:00:00Z","timestamp":1560643200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2019,6,16]],"date-time":"2019-06-16T00:00:00Z","timestamp":1560643200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/100000049","name":"National Institute on Aging","doi-asserted-by":"publisher","award":["P01AG014930"],"award-info":[{"award-number":["P01AG014930"]}],"id":[{"id":"10.13039\/100000049","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Neurobiol"],"published-print":{"date-parts":[[2019,12]]},"DOI":"10.1007\/s12035-019-01665-y","type":"journal-article","created":{"date-parts":[[2019,6,15]],"date-time":"2019-06-15T23:03:47Z","timestamp":1560639827000},"page":"8220-8236","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":74,"title":["Autophagy Induction by Bexarotene Promotes Mitophagy in Presenilin 1 Familial Alzheimer\u2019s Disease iPSC-Derived Neural Stem Cells"],"prefix":"10.1007","volume":"56","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-6247-6950","authenticated-orcid":false,"given":"Patricia","family":"Mart\u00edn-Maestro","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew","family":"Sproul","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hector","family":"Martinez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dominik","family":"Paquet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meri","family":"Gerges","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Scott","family":"Noggle","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anatoly A.","family":"Starkov","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,6,16]]},"reference":[{"issue":"5580","key":"1665_CR1","doi-asserted-by":"publisher","first-page":"353","DOI":"10.1126\/science.1072994","volume":"297","author":"J Hardy","year":"2002","unstructured":"Hardy J, Selkoe DJ (2002) The amyloid hypothesis of Alzheimer\u2019s disease: progress and problems on the road to therapeutics. Science 297(5580):353\u2013356","journal-title":"Science"},{"issue":"114","key":"1665_CR2","doi-asserted-by":"publisher","first-page":"114ps48","DOI":"10.1126\/scitranslmed.3003529","volume":"3","author":"DM Holtzman","year":"2011","unstructured":"Holtzman DM et al (2011) Mapping the road forward in Alzheimer\u2019s disease. Sci Transl Med 3(114):114ps48","journal-title":"Sci Transl Med"},{"issue":"1","key":"1665_CR3","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1080\/15548627.2015.1100356","volume":"12","author":"DJ Klionsky","year":"2016","unstructured":"Klionsky DJ et al (2016) Guidelines for the use and interpretation of assays for monitoring autophagy (3rd edition). Autophagy 12(1):1\u2013222","journal-title":"Autophagy"},{"issue":"1","key":"1665_CR4","doi-asserted-by":"publisher","first-page":"99","DOI":"10.2217\/bmm.09.92","volume":"4","author":"NS Ryan","year":"2010","unstructured":"Ryan NS, Rossor MN (2010) Correlating familial Alzheimer\u2019s disease gene mutations with clinical phenotype. Biomark Med 4(1):99\u2013112","journal-title":"Biomark Med"},{"issue":"5","key":"1665_CR5","doi-asserted-by":"publisher","first-page":"1005","DOI":"10.1016\/S0896-6273(00)80230-5","volume":"17","author":"DR Borchelt","year":"1996","unstructured":"Borchelt DR, Thinakaran G, Eckman CB, Lee MK, Davenport F, Ratovitsky T, Prada CM, Kim G et al (1996) Familial Alzheimer\u2019s disease-linked presenilin 1 variants elevate Abeta1-42\/1-40 ratio in vitro and in vivo. Neuron 17(5):1005\u20131013","journal-title":"Neuron"},{"issue":"4","key":"1665_CR6","doi-asserted-by":"publisher","first-page":"645","DOI":"10.1016\/j.cell.2008.01.033","volume":"132","author":"C Zhao","year":"2008","unstructured":"Zhao C, Deng W, Gage FH (2008) Mechanisms and functional implications of adult neurogenesis. Cell 132(4):645\u2013660","journal-title":"Cell"},{"key":"1665_CR7","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1186\/1750-1326-6-85","volume":"6","author":"Y Mu","year":"2011","unstructured":"Mu Y, Gage FH (2011) Adult hippocampal neurogenesis and its role in Alzheimer\u2019s disease. Mol Neurodegener 6:85","journal-title":"Mol Neurodegener"},{"issue":"10","key":"1665_CR8","doi-asserted-by":"publisher","first-page":"2103","DOI":"10.1002\/jnr.22387","volume":"88","author":"M Demars","year":"2010","unstructured":"Demars M et al (2010) Impaired neurogenesis is an early event in the etiology of familial Alzheimer\u2019s disease in transgenic mice. J Neurosci Res 88(10):2103\u20132117","journal-title":"J Neurosci Res"},{"issue":"1","key":"1665_CR9","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1097\/nen.0b013e318160c5db","volume":"67","author":"B Li","year":"2008","unstructured":"Li B et al (2008) Failure of neuronal maturation in Alzheimer disease dentate gyrus. J Neuropathol Exp Neurol 67(1):78\u201384","journal-title":"J Neuropathol Exp Neurol"},{"issue":"6630","key":"1665_CR10","doi-asserted-by":"publisher","first-page":"288","DOI":"10.1038\/387288a0","volume":"387","author":"PC Wong","year":"1997","unstructured":"Wong PC, Zheng H, Chen H, Becher MW, Sirinathsinghji DJ, Trumbauer ME, Chen HY, Price DL et al (1997) Presenilin 1 is required for Notch1 and DII1 expression in the paraxial mesoderm. Nature 387(6630):288\u2013292","journal-title":"Nature"},{"issue":"4","key":"1665_CR11","doi-asserted-by":"publisher","first-page":"629","DOI":"10.1016\/S0092-8674(00)80244-5","volume":"89","author":"J Shen","year":"1997","unstructured":"Shen J, Bronson RT, Chen DF, Xia W, Selkoe DJ, Tonegawa S (1997) Skeletal and CNS defects in Presenilin-1-deficient mice. Cell 89(4):629\u2013639","journal-title":"Cell"},{"issue":"2","key":"1665_CR12","doi-asserted-by":"publisher","first-page":"316","DOI":"10.1016\/j.nbd.2007.09.005","volume":"29","author":"Q Chen","year":"2008","unstructured":"Chen Q, Nakajima A, Choi SH, Xiong X, Sisodia SS, Tang YP (2008) Adult neurogenesis is functionally associated with AD-like neurodegeneration. Neurobiol Dis 29(2):316\u2013326","journal-title":"Neurobiol Dis"},{"issue":"6","key":"1665_CR13","doi-asserted-by":"publisher","first-page":"1509","DOI":"10.1046\/j.1471-4159.2002.01267.x","volume":"83","author":"NJ Haughey","year":"2002","unstructured":"Haughey NJ et al (2002) Disruption of neurogenesis by amyloid beta-peptide, and perturbed neural progenitor cell homeostasis, in models of Alzheimer\u2019s disease. J Neurochem 83(6):1509\u20131524","journal-title":"J Neurochem"},{"issue":"1","key":"1665_CR14","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1016\/j.expneurol.2006.09.018","volume":"204","author":"C Zhang","year":"2007","unstructured":"Zhang C et al (2007) Long-lasting impairment in hippocampal neurogenesis associated with amyloid deposition in a knock-in mouse model of familial Alzheimer\u2019s disease. Exp Neurol 204(1):77\u201387","journal-title":"Exp Neurol"},{"issue":"2","key":"1665_CR15","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1016\/j.expneurol.2009.08.009","volume":"223","author":"O Lazarov","year":"2010","unstructured":"Lazarov O, Marr RA (2010) Neurogenesis and Alzheimer\u2019s disease: at the crossroads. Exp Neurol 223(2):267\u2013281","journal-title":"Exp Neurol"},{"issue":"3","key":"1665_CR16","doi-asserted-by":"publisher","first-page":"547","DOI":"10.1023\/B:NERE.0000014825.42365.16","volume":"29","author":"S Papa","year":"2004","unstructured":"Papa S et al (2004) Respiratory complex I in brain development and genetic disease. Neurochem Res 29(3):547\u2013560","journal-title":"Neurochem Res"},{"issue":"4","key":"1665_CR17","doi-asserted-by":"publisher","first-page":"986","DOI":"10.1016\/j.neuroscience.2008.02.071","volume":"153","author":"NY Calingasan","year":"2008","unstructured":"Calingasan NY et al (2008) Influence of mitochondrial enzyme deficiency on adult neurogenesis in mouse models of neurodegenerative diseases. Neuroscience 153(4):986\u2013996","journal-title":"Neuroscience"},{"key":"1665_CR18","unstructured":"Kathleen Baxter K et al (2009) The neurogenic basic helix-loop-helix transcription factor NeuroD6 concomitantly increases mitochondrial mass and regulates cytoskeletal organization in the early stages of neuronal differentiation. ASN Neuro 1(4):195\u2013211"},{"issue":"4","key":"1665_CR19","doi-asserted-by":"publisher","first-page":"413","DOI":"10.1111\/j.1365-2184.2009.00612.x","volume":"42","author":"DM Kirby","year":"2009","unstructured":"Kirby DM, Rennie KJ, Smulders-Srinivasan TK, Acin-Perez R, Whittington M, Enriquez JA, Trevelyan AJ, Turnbull DM et al (2009) Transmitochondrial embryonic stem cells containing pathogenic mtDNA mutations are compromised in neuronal differentiation. Cell Prolif 42(4):413\u2013424","journal-title":"Cell Prolif"},{"issue":"12","key":"1665_CR20","doi-asserted-by":"publisher","first-page":"1989","DOI":"10.1002\/jnr.22768","volume":"89","author":"LA Voloboueva","year":"2011","unstructured":"Voloboueva LA, Giffard RG (2011) Inflammation, mitochondria, and the inhibition of adult neurogenesis. J Neurosci Res 89(12):1989\u20131996","journal-title":"J Neurosci Res"},{"issue":"2","key":"1665_CR21","doi-asserted-by":"publisher","first-page":"232","DOI":"10.1016\/j.stem.2016.04.015","volume":"19","author":"M Khacho","year":"2016","unstructured":"Khacho M et al (2016) Mitochondrial dynamics impacts stem cell identity and fate decisions by regulating a nuclear transcriptional program. Cell Stem Cell 19(2):232\u2013247","journal-title":"Cell Stem Cell"},{"issue":"4\u20135","key":"1665_CR22","doi-asserted-by":"publisher","first-page":"290","DOI":"10.1016\/j.neuropharm.2010.04.005","volume":"59","author":"DJ Bonda","year":"2010","unstructured":"Bonda DJ, Wang X, Perry G, Nunomura A, Tabaton M, Zhu X, Smith MA (2010) Oxidative stress in Alzheimer disease: a possibility for prevention. Neuropharmacology 59(4\u20135):290\u2013294","journal-title":"Neuropharmacology"},{"issue":"1","key":"1665_CR23","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1089\/rej.2005.8.3","volume":"8","author":"JJ Lemasters","year":"2005","unstructured":"Lemasters JJ (2005) Selective mitochondrial autophagy, or mitophagy, as a targeted defense against oxidative stress, mitochondrial dysfunction, and aging. Rejuvenation Res 8(1):3\u20135","journal-title":"Rejuvenation Res"},{"issue":"1","key":"1665_CR24","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1038\/nrm3028","volume":"12","author":"RJ Youle","year":"2011","unstructured":"Youle RJ, Narendra DP (2011) Mechanisms of mitophagy. Nat Rev Mol Cell Biol 12(1):9\u201314","journal-title":"Nat Rev Mol Cell Biol"},{"issue":"1","key":"1665_CR25","doi-asserted-by":"publisher","first-page":"e1000298","DOI":"10.1371\/journal.pbio.1000298","volume":"8","author":"DP Narendra","year":"2010","unstructured":"Narendra DP et al (2010) PINK1 is selectively stabilized on impaired mitochondria to activate Parkin. PLoS Biol 8(1):e1000298","journal-title":"PLoS Biol"},{"issue":"1","key":"1665_CR26","doi-asserted-by":"publisher","first-page":"378","DOI":"10.1073\/pnas.0911187107","volume":"107","author":"C Vives-Bauza","year":"2010","unstructured":"Vives-Bauza C, Zhou C, Huang Y, Cui M, de Vries RLA, Kim J, May J, Tocilescu MA et al (2010) PINK1-dependent recruitment of Parkin to mitochondria in mitophagy. Proc Natl Acad Sci U S A 107(1):378\u2013383","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"2","key":"1665_CR27","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1038\/ncb2012","volume":"12","author":"S Geisler","year":"2010","unstructured":"Geisler S et al (2010) PINK1\/Parkin-mediated mitophagy is dependent on VDAC1 and p62\/SQSTM1. Nat Cell Biol 12(2):119\u2013131","journal-title":"Nat Cell Biol"},{"issue":"24","key":"1665_CR28","doi-asserted-by":"publisher","first-page":"4861","DOI":"10.1093\/hmg\/ddq419","volume":"19","author":"ME Gegg","year":"2010","unstructured":"Gegg ME, Cooper JM, Chau KY, Rojo M, Schapira AHV, Taanman JW (2010) Mitofusin 1 and mitofusin 2 are ubiquitinated in a PINK1\/parkin-dependent manner upon induction of mitophagy. Hum Mol Genet 19(24):4861\u20134870","journal-title":"Hum Mol Genet"},{"issue":"4","key":"1665_CR29","doi-asserted-by":"publisher","first-page":"603","DOI":"10.1083\/jcb.200507002","volume":"171","author":"G Bjorkoy","year":"2005","unstructured":"Bjorkoy G et al (2005) p62\/SQSTM1 forms protein aggregates degraded by autophagy and has a protective effect on huntingtin-induced cell death. J Cell Biol 171(4):603\u2013614","journal-title":"J Cell Biol"},{"issue":"4","key":"1665_CR30","doi-asserted-by":"publisher","first-page":"792","DOI":"10.1093\/hmg\/ddv616","volume":"25","author":"P Martin-Maestro","year":"2016","unstructured":"Martin-Maestro P et al (2016) PARK2 enhancement is able to compensate mitophagy alterations found in sporadic Alzheimer\u2019s disease. Hum Mol Genet 25(4):792\u2013806","journal-title":"Hum Mol Genet"},{"key":"1665_CR31","doi-asserted-by":"publisher","first-page":"291","DOI":"10.3389\/fnmol.2017.00291","volume":"10","author":"P Martin-Maestro","year":"2017","unstructured":"Martin-Maestro P et al (2017) Mitophagy failure in fibroblasts and iPSC-derived neurons of Alzheimer\u2019s disease-associated presenilin 1 mutation. Front Mol Neurosci 10:291","journal-title":"Front Mol Neurosci"},{"issue":"6","key":"1665_CR32","doi-asserted-by":"publisher","first-page":"614","DOI":"10.4161\/auto.4872","volume":"3","author":"PI Moreira","year":"2007","unstructured":"Moreira PI, Siedlak SL, Wang X, Santos MS, Oliveira CR, Tabaton M, Nunomura A, Szweda LI et al (2007) Increased autophagic degradation of mitochondria in Alzheimer disease. Autophagy 3(6):614\u2013615","journal-title":"Autophagy"},{"issue":"6","key":"1665_CR33","doi-asserted-by":"publisher","first-page":"525","DOI":"10.1097\/01.jnen.0000240476.73532.b0","volume":"66","author":"PI Moreira","year":"2007","unstructured":"Moreira PI et al (2007) Autophagocytosis of mitochondria is prominent in Alzheimer disease. J Neuropathol Exp Neurol 66(6):525\u2013532","journal-title":"J Neuropathol Exp Neurol"},{"key":"1665_CR34","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1016\/j.pbb.2014.02.016","volume":"120","author":"RK Sodhi","year":"2014","unstructured":"Sodhi RK, Singh N (2014) Retinoids as potential targets for Alzheimer\u2019s disease. Pharmacol Biochem Behav 120:117\u2013123","journal-title":"Pharmacol Biochem Behav"},{"issue":"9","key":"1665_CR35","doi-asserted-by":"publisher","first-page":"1131","DOI":"10.1001\/jama.283.9.1131-JFD00001-2-1","volume":"283","author":"JE Henney","year":"2000","unstructured":"Henney JE (2000) From the Food and Drug Administration. JAMA 283(9):1131","journal-title":"JAMA"},{"key":"1665_CR36","first-page":"40","volume":"1","author":"MC Abba","year":"2008","unstructured":"Abba MC, Hu Y, Levy CC, Gaddis S, Kittrell FS, Zhang Y, Hill J, Bissonnette RP et al (2008) Transcriptomic signature of bexarotene (rexinoid LGD1069) on mammary gland from three transgenic mouse mammary cancer models. BMC Med Genet 1:40","journal-title":"BMC Med Genet"},{"issue":"11","key":"1665_CR37","doi-asserted-by":"publisher","first-page":"1430","DOI":"10.1021\/cn400100f","volume":"4","author":"K McFarland","year":"2013","unstructured":"McFarland K, Spalding TA, Hubbard D, Ma JN, Olsson R, Burstein ES (2013) Low dose bexarotene treatment rescues dopamine neurons and restores behavioral function in models of Parkinson's disease. ACS Chem Neurosci 4(11):1430\u20131438","journal-title":"ACS Chem Neurosci"},{"key":"1665_CR38","doi-asserted-by":"publisher","first-page":"250","DOI":"10.3389\/fncel.2015.00250","volume":"9","author":"J Riancho","year":"2015","unstructured":"Riancho J et al (2015) Neuroprotective effect of bexarotene in the SOD1(G93A) mouse model of amyotrophic lateral sclerosis. Front Cell Neurosci 9:250","journal-title":"Front Cell Neurosci"},{"issue":"9","key":"1665_CR39","doi-asserted-by":"publisher","first-page":"2091","DOI":"10.1016\/j.neurobiolaging.2014.03.029","volume":"35","author":"V Bomben","year":"2014","unstructured":"Bomben V et al (2014) Bexarotene reduces network excitability in models of Alzheimer\u2019s disease and epilepsy. Neurobiol Aging 35(9):2091\u20132095","journal-title":"Neurobiol Aging"},{"issue":"6075","key":"1665_CR40","doi-asserted-by":"publisher","first-page":"1503","DOI":"10.1126\/science.1217697","volume":"335","author":"PE Cramer","year":"2012","unstructured":"Cramer PE et al (2012) ApoE-directed therapeutics rapidly clear beta-amyloid and reverse deficits in AD mouse models. Science 335(6075):1503\u20131506","journal-title":"Science"},{"issue":"10","key":"1665_CR41","doi-asserted-by":"publisher","first-page":"1937","DOI":"10.1194\/jlr.R075556","volume":"58","author":"M Moutinho","year":"2017","unstructured":"Moutinho M, Landreth GE (2017) Therapeutic potential of nuclear receptor agonists in Alzheimer\u2019s disease. J Lipid Res 58(10):1937\u20131949","journal-title":"J Lipid Res"},{"key":"1665_CR42","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1186\/s13195-016-0173-2","volume":"8","author":"JL Cummings","year":"2016","unstructured":"Cummings JL et al (2016) Double-blind, placebo-controlled, proof-of-concept trial of bexarotene Xin moderate Alzheimer's disease. Alzheimers Res Ther 8:4","journal-title":"Alzheimers Res Ther"},{"issue":"2","key":"1665_CR43","doi-asserted-by":"publisher","first-page":"271","DOI":"10.3233\/JAD-150405","volume":"49","author":"N Pierrot","year":"2016","unstructured":"Pierrot N, Lhommel R, Quenon L, Hanseeuw B, Dricot L, Sindic C, Maloteaux JM, Octavea JN et al (2016) Targretin improves cognitive and biological markers in a patient with Alzheimer\u2019s disease. J Alzheimers Dis 49(2):271\u2013276","journal-title":"J Alzheimers Dis"},{"issue":"21","key":"1665_CR44","doi-asserted-by":"publisher","first-page":"7293","DOI":"10.1523\/JNEUROSCI.5198-13.2014","volume":"34","author":"A Boehm-Cagan","year":"2014","unstructured":"Boehm-Cagan A, Michaelson DM (2014) Reversal of apoE4-driven brain pathology and behavioral deficits by bexarotene. J Neurosci 34(21):7293\u20137301","journal-title":"J Neurosci"},{"issue":"1","key":"1665_CR45","doi-asserted-by":"publisher","first-page":"e84547","DOI":"10.1371\/journal.pone.0084547","volume":"9","author":"AA Sproul","year":"2014","unstructured":"Sproul AA et al (2014) Characterization and molecular profiling of PSEN1 familial Alzheimer\u2019s disease iPSC-derived neural progenitors. PLoS One 9(1):e84547","journal-title":"PLoS One"},{"issue":"7601","key":"1665_CR46","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1038\/nature17664","volume":"533","author":"D Paquet","year":"2016","unstructured":"Paquet D et al (2016) Efficient introduction of specific homozygous and heterozygous mutations using CRISPR\/Cas9. Nature 533(7601):125\u2013129","journal-title":"Nature"},{"issue":"5","key":"1665_CR47","doi-asserted-by":"publisher","first-page":"585","DOI":"10.4161\/auto.5.5.8823","volume":"5","author":"DC Rubinsztein","year":"2009","unstructured":"Rubinsztein DC, Cuervo AM, Ravikumar B, Sarkar S, Korolchuk VI, Kaushik S, Klionsky DJ (2009) In search of an \u201cautophagomometer\u201d. Autophagy 5(5):585\u2013589","journal-title":"Autophagy"},{"issue":"1","key":"1665_CR48","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.bbrc.2011.06.067","volume":"412","author":"AN Malik","year":"2011","unstructured":"Malik AN et al (2011) Mitochondrial DNA as a non-invasive biomarker: accurate quantification using real time quantitative PCR without co-amplification of pseudogenes and dilution bias. Biochem Biophys Res Commun 412(1):1\u20137","journal-title":"Biochem Biophys Res Commun"},{"issue":"2\u20133","key":"1665_CR49","doi-asserted-by":"publisher","first-page":"262","DOI":"10.1016\/0005-2728(93)90051-G","volume":"1141","author":"VD Sled","year":"1993","unstructured":"Sled VD, Vinogradov AD (1993) Kinetics of the mitochondrial NADH-ubiquinone oxidoreductase interaction with hexammineruthenium(III). Biochim Biophys Acta 1141(2\u20133):262\u2013268","journal-title":"Biochim Biophys Acta"},{"key":"1665_CR50","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1016\/j.neurobiolaging.2016.01.132","volume":"40","author":"MC Chiang","year":"2016","unstructured":"Chiang MC, Nicol CJ, Cheng YC, Lin KH, Yen CH, Lin CH (2016) Rosiglitazone activation of PPARgamma-dependent pathways is neuroprotective in human neural stem cells against amyloid-beta-induced mitochondrial dysfunction and oxidative stress. Neurobiol Aging 40:181\u2013190","journal-title":"Neurobiol Aging"},{"issue":"2","key":"1665_CR51","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1385\/NMM:5:2:147","volume":"5","author":"M Manczak","year":"2004","unstructured":"Manczak M, Park BS, Jung Y, Reddy PH (2004) Differential expression of oxidative phosphorylation genes in patients with Alzheimer\u2019s disease: implications for early mitochondrial dysfunction and oxidative damage. NeuroMolecular Med 5(2):147\u2013162","journal-title":"NeuroMolecular Med"},{"issue":"47","key":"1665_CR52","doi-asserted-by":"publisher","first-page":"20057","DOI":"10.1073\/pnas.0905529106","volume":"106","author":"V Rhein","year":"2009","unstructured":"Rhein V, Song X, Wiesner A, Ittner LM, Baysang G, Meier F, Ozmen L, Bluethmann H et al (2009) Amyloid-beta and tau synergistically impair the oxidative phosphorylation system in triple transgenic Alzheimer\u2019s disease mice. Proc Natl Acad Sci U S A 106(47):20057\u201320062","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"12","key":"1665_CR53","doi-asserted-by":"publisher","first-page":"3649","DOI":"10.1177\/0271678X17730242","volume":"37","author":"A Stepanova","year":"2017","unstructured":"Stepanova A, Kahl A, Konrad C, ten V, Starkov AS, Galkin A (2017) Reverse electron transfer results in a loss of flavin from mitochondrial complex I: potential mechanism for brain ischemia reperfusion injury. J Cereb Blood Flow Metab 37(12):3649\u20133658","journal-title":"J Cereb Blood Flow Metab"},{"issue":"5","key":"1665_CR54","doi-asserted-by":"publisher","first-page":"1223","DOI":"10.1161\/STROKEAHA.117.019687","volume":"49","author":"A Kahl","year":"2018","unstructured":"Kahl A, Stepanova A, Konrad C, Anderson C, Manfredi G, Zhou P, Iadecola C, Galkin A (2018) Critical role of flavin and glutathione in complex I-mediated bioenergetic failure in brain ischemia\/reperfusion injury. Stroke 49(5):1223\u20131231","journal-title":"Stroke"},{"issue":"13","key":"1665_CR55","doi-asserted-by":"publisher","first-page":"2475","DOI":"10.1242\/jcs.146365","volume":"129","author":"G Napolitano","year":"2016","unstructured":"Napolitano G, Ballabio A (2016) TFEB at a glance. J Cell Sci 129(13):2475\u20132481","journal-title":"J Cell Sci"},{"issue":"11","key":"1665_CR56","doi-asserted-by":"publisher","first-page":"e98804","DOI":"10.15252\/embj.201798804","volume":"37","author":"R Puertollano","year":"2018","unstructured":"Puertollano R, Ferguson SM, Brugarolas J, Ballabio A (2018) The complex relationship between TFEB transcription factor phosphorylation and subcellular localization. EMBO J 37(11):e98804","journal-title":"EMBO J"},{"issue":"2","key":"1665_CR57","doi-asserted-by":"publisher","first-page":"132","DOI":"10.1038\/ncb2152","volume":"13","author":"J Kim","year":"2011","unstructured":"Kim J et al (2011) AMPK and mTOR regulate autophagy through direct phosphorylation of Ulk1. Nat Cell Biol 13(2):132\u2013141","journal-title":"Nat Cell Biol"},{"issue":"7","key":"1665_CR58","doi-asserted-by":"publisher","first-page":"1146","DOI":"10.1016\/j.cell.2010.05.008","volume":"141","author":"JH Lee","year":"2010","unstructured":"Lee JH et al (2010) Lysosomal proteolysis and autophagy require presenilin 1 and are disrupted by Alzheimer-related PS1 mutations. Cell 141(7):1146\u20131158","journal-title":"Cell"},{"key":"1665_CR59","doi-asserted-by":"publisher","first-page":"1024","DOI":"10.3389\/fimmu.2018.01024","volume":"9","author":"TA Ryan","year":"2018","unstructured":"Ryan TA, Tumbarello DA (2018) Optineurin: a coordinator of membrane-associated cargo trafficking and autophagy. Front Immunol 9:1024","journal-title":"Front Immunol"},{"issue":"10","key":"1665_CR60","doi-asserted-by":"publisher","first-page":"1929","DOI":"10.1089\/ars.2010.3799","volume":"14","author":"DP Narendra","year":"2011","unstructured":"Narendra DP, Youle RJ (2011) Targeting mitochondrial dysfunction: role for PINK1 and Parkin in mitochondrial quality control. Antioxid Redox Signal 14(10):1929\u20131938","journal-title":"Antioxid Redox Signal"},{"key":"1665_CR61","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1016\/j.redox.2014.11.006","volume":"4","author":"HM Ni","year":"2015","unstructured":"Ni HM, Williams JA, Ding WX (2015) Mitochondrial dynamics and mitochondrial quality control. Redox Biol 4:6\u201313","journal-title":"Redox Biol"},{"issue":"5","key":"1665_CR62","doi-asserted-by":"publisher","first-page":"659","DOI":"10.1091\/mbc.e12-10-0721","volume":"24","author":"OC Loson","year":"2013","unstructured":"Loson OC et al (2013) Fis1, Mff, MiD49, and MiD51 mediate Drp1 recruitment in mitochondrial fission. Mol Biol Cell 24(5):659\u2013667","journal-title":"Mol Biol Cell"},{"issue":"6","key":"1665_CR63","doi-asserted-by":"publisher","first-page":"565","DOI":"10.1038\/embor.2011.54","volume":"12","author":"CS Palmer","year":"2011","unstructured":"Palmer CS et al (2011) MiD49 and MiD51, new components of the mitochondrial fission machinery. EMBO Rep 12(6):565\u2013573","journal-title":"EMBO Rep"},{"issue":"28","key":"1665_CR64","doi-asserted-by":"publisher","first-page":"9090","DOI":"10.1523\/JNEUROSCI.1357-09.2009","volume":"29","author":"X Wang","year":"2009","unstructured":"Wang X, Su B, Lee HG, Li X, Perry G, Smith MA, Zhu X (2009) Impaired balance of mitochondrial fission and fusion in Alzheimer\u2019s disease. J Neurosci 29(28):9090\u20139103","journal-title":"J Neurosci"},{"issue":"2","key":"1665_CR65","doi-asserted-by":"publisher","first-page":"470","DOI":"10.2353\/ajpath.2008.071208","volume":"173","author":"X Wang","year":"2008","unstructured":"Wang X, Su B, Fujioka H, Zhu X (2008) Dynamin-like protein 1 reduction underlies mitochondrial morphology and distribution abnormalities in fibroblasts from sporadic Alzheimer\u2019s disease patients. Am J Pathol 173(2):470\u2013482","journal-title":"Am J Pathol"},{"key":"1665_CR66","doi-asserted-by":"publisher","first-page":"9302761","DOI":"10.1155\/2017\/9302761","volume":"2017","author":"P Martin-Maestro","year":"2017","unstructured":"Martin-Maestro P et al (2017) Slower dynamics and aged mitochondria in sporadic Alzheimer\u2019s disease. Oxidative Med Cell Longev 2017:9302761","journal-title":"Oxidative Med Cell Longev"},{"issue":"8","key":"1665_CR67","doi-asserted-by":"publisher","first-page":"2245","DOI":"10.1091\/mbc.12.8.2245","volume":"12","author":"E Smirnova","year":"2001","unstructured":"Smirnova E, Griparic L, Shurland DL, van der Bliek A (2001) Dynamin-related protein Drp1 is required for mitochondrial division in mammalian cells. Mol Biol Cell 12(8):2245\u20132256","journal-title":"Mol Biol Cell"},{"issue":"3","key":"1665_CR68","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1016\/j.acthis.2017.03.001","volume":"119","author":"AJ Valente","year":"2017","unstructured":"Valente AJ, Maddalena LA, Robb EL, Moradi F, Stuart JA (2017) A simple ImageJ macro tool for analyzing mitochondrial network morphology in mammalian cell culture. Acta Histochem 119(3):315\u2013326","journal-title":"Acta Histochem"},{"issue":"5","key":"1665_CR69","doi-asserted-by":"publisher","first-page":"967","DOI":"10.1016\/j.neuron.2015.02.010","volume":"85","author":"D Xia","year":"2015","unstructured":"Xia D, Watanabe H, Wu B, Lee SH, Li Y, Tsvetkov E, Bolshakov VY, Shen J et al (2015) Presenilin-1 knockin mice reveal loss-of-function mechanism for familial Alzheimer\u2019s disease. Neuron 85(5):967\u2013981","journal-title":"Neuron"},{"issue":"1","key":"1665_CR70","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1016\/S0896-6273(04)00182-5","volume":"42","author":"CA Saura","year":"2004","unstructured":"Saura CA, Choi SY, Beglopoulos V, Malkani S, Zhang D, Rao BSS, Chattarji S, Kelleher RJ III et al (2004) Loss of presenilin function causes impairments of memory and synaptic plasticity followed by age-dependent neurodegeneration. Neuron 42(1):23\u201336","journal-title":"Neuron"},{"issue":"4","key":"1665_CR71","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0010195","volume":"5","author":"M Wines-Samuelson","year":"2010","unstructured":"Wines-Samuelson M, Schulte EC, Smith MJ, Aoki C, Liu X, Kelleher RJ, Shen J (2010) Characterization of age-dependent and progressive cortical neuronal degeneration in presenilin conditional mutant mice. PLoS One 5(4):e10195","journal-title":"PLoS One"},{"key":"1665_CR72","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1186\/1750-1326-8-41","volume":"8","author":"K Veeraraghavalu","year":"2013","unstructured":"Veeraraghavalu K, Choi S, Zhang X, Sisodia SS (2013) Endogenous expression of FAD-linked PS1 impairs proliferation, neuronal differentiation and survival of adult hippocampal progenitors. Mol Neurodegener 8:41","journal-title":"Mol Neurodegener"},{"issue":"6534","key":"1665_CR73","doi-asserted-by":"publisher","first-page":"754","DOI":"10.1038\/375754a0","volume":"375","author":"R Sherrington","year":"1995","unstructured":"Sherrington R et al (1995) Cloning of a gene bearing missense mutations in early-onset familial Alzheimer\u2019s disease. Nature 375(6534):754\u2013760","journal-title":"Nature"},{"issue":"10","key":"1665_CR74","doi-asserted-by":"publisher","first-page":"798","DOI":"10.1212\/WNL.0b013e3181d52785","volume":"74","author":"AC Bruni","year":"2010","unstructured":"Bruni AC et al (2010) Worldwide distribution of PSEN1 Met146Leu mutation: a large variability for a founder mutation. Neurology 74(10):798\u2013806","journal-title":"Neurology"},{"issue":"2","key":"1665_CR75","doi-asserted-by":"publisher","first-page":"677","DOI":"10.1074\/jbc.M708754200","volume":"283","author":"RM Page","year":"2008","unstructured":"Page RM, Baumann K, Tomioka M, P\u00e9rez-Revuelta BI, Fukumori A, Jacobsen H, Flohr A, Luebbers T et al (2008) Generation of Abeta38 and Abeta42 is independently and differentially affected by familial Alzheimer disease-associated presenilin mutations and gamma-secretase modulation. J Biol Chem 283(2):677\u2013683","journal-title":"J Biol Chem"},{"issue":"1","key":"1665_CR76","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1006\/bbrc.2000.4107","volume":"280","author":"E Kuusisto","year":"2001","unstructured":"Kuusisto E, Suuronen T, Salminen A (2001) Ubiquitin-binding protein p62 expression is induced during apoptosis and proteasomal inhibition in neuronal cells. Biochem Biophys Res Commun 280(1):223\u2013228","journal-title":"Biochem Biophys Res Commun"},{"issue":"3","key":"1665_CR77","doi-asserted-by":"publisher","first-page":"228","DOI":"10.1046\/j.1365-2990.2002.00394.x","volume":"28","author":"E Kuusisto","year":"2002","unstructured":"Kuusisto E, Salminen A, Alafuzoff I (2002) Early accumulation of p62 in neurofibrillary tangles in Alzheimer's disease: possible role in tangle formation. Neuropathol Appl Neurobiol 28(3):228\u2013237","journal-title":"Neuropathol Appl Neurobiol"},{"key":"1665_CR78","doi-asserted-by":"publisher","first-page":"45076","DOI":"10.1038\/srep45076","volume":"7","author":"L Fernandez-Mosquera","year":"2017","unstructured":"Fernandez-Mosquera L et al (2017) Acute and chronic mitochondrial respiratory chain deficiency differentially regulate lysosomal biogenesis. Sci Rep 7:45076","journal-title":"Sci Rep"},{"issue":"7","key":"1665_CR79","doi-asserted-by":"publisher","first-page":"1386","DOI":"10.1016\/j.febslet.2010.02.060","volume":"584","author":"A Tanaka","year":"2010","unstructured":"Tanaka A (2010) Parkin-mediated selective mitochondrial autophagy, mitophagy: Parkin purges damaged organelles from the vital mitochondrial network. FEBS Lett 584(7):1386\u20131392","journal-title":"FEBS Lett"},{"issue":"1","key":"1665_CR80","doi-asserted-by":"publisher","first-page":"231","DOI":"10.3233\/JAD-2012-121141","volume":"33","author":"I Lonskaya","year":"2013","unstructured":"Lonskaya I, Shekoyan AR, Hebron ML, Desforges N, Algarzae NK, Moussa CE (2013) Diminished parkin solubility and co-localization with intraneuronal amyloid-beta are associated with autophagic defects in Alzheimer's disease. J Alzheimers Dis 33(1):231\u2013247","journal-title":"J Alzheimers Dis"},{"issue":"3","key":"1665_CR81","doi-asserted-by":"publisher","first-page":"445","DOI":"10.1016\/j.nbd.2009.08.009","volume":"36","author":"ME Witte","year":"2009","unstructured":"Witte ME, Bol JGJM, Gerritsen WH, Valk P, Drukarch B, Horssen J, Wilhelmus MMM (2009) Parkinson's disease-associated parkin colocalizes with Alzheimer\u2019s disease and multiple sclerosis brain lesions. Neurobiol Dis 36(3):445\u2013452","journal-title":"Neurobiol Dis"},{"issue":"3","key":"1665_CR82","doi-asserted-by":"publisher","first-page":"e0150441","DOI":"10.1371\/journal.pone.0150441","volume":"11","author":"L Wang","year":"2016","unstructured":"Wang L et al (2016) Synaptosomal mitochondrial dysfunction in 5xFAD mouse model of Alzheimer\u2019s disease. PLoS One 11(3):e0150441","journal-title":"PLoS One"},{"issue":"3","key":"1665_CR83","doi-asserted-by":"publisher","first-page":"401","DOI":"10.1038\/s41593-018-0332-9","volume":"22","author":"EF Fang","year":"2019","unstructured":"Fang EF et al (2019) Mitophagy inhibits amyloid-beta and tau pathology and reverses cognitive deficits in models of Alzheimer\u2019s disease. Nat Neurosci 22(3):401\u2013412","journal-title":"Nat Neurosci"},{"issue":"10","key":"1665_CR84","doi-asserted-by":"publisher","first-page":"2938","DOI":"10.1093\/hmg\/ddv056","volume":"24","author":"X Ye","year":"2015","unstructured":"Ye X et al (2015) Parkin-mediated mitophagy in mutant hAPP neurons and Alzheimer\u2019s disease patient brains. Hum Mol Genet 24(10):2938\u20132951","journal-title":"Hum Mol Genet"},{"key":"1665_CR85","doi-asserted-by":"publisher","first-page":"162152","DOI":"10.1155\/2013\/162152","volume":"2013","author":"V Garcia-Escudero","year":"2013","unstructured":"Garcia-Escudero V et al (2013) Deconstructing mitochondrial dysfunction in Alzheimer disease. Oxidative Med Cell Longev 2013:162152","journal-title":"Oxidative Med Cell Longev"},{"issue":"49","key":"1665_CR86","doi-asserted-by":"publisher","first-page":"19318","DOI":"10.1073\/pnas.0804871105","volume":"105","author":"X Wang","year":"2008","unstructured":"Wang X, Su B, Siedlak SL, Moreira PI, Fujioka H, Wang Y, Casadesus G, Zhu X (2008) Amyloid-beta overproduction causes abnormal mitochondrial dynamics via differential modulation of mitochondrial fission\/fusion proteins. Proc Natl Acad Sci U S A 105(49):19318\u201319323","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"7","key":"1665_CR87","doi-asserted-by":"publisher","first-page":"505","DOI":"10.1038\/nrn2417","volume":"9","author":"AB Knott","year":"2008","unstructured":"Knott AB, Perkins G, Schwarzenbacher R, Bossy-Wetzel E (2008) Mitochondrial fragmentation in neurodegeneration. Nat Rev Neurosci 9(7):505\u2013518","journal-title":"Nat Rev Neurosci"},{"issue":"6135","key":"1665_CR88","doi-asserted-by":"publisher","first-page":"924","DOI":"10.1126\/science.1235505","volume":"340","author":"K Veeraraghavalu","year":"2013","unstructured":"Veeraraghavalu K, Zhang C, Miller S, Hefendehl JK, Rajapaksha TW, Ulrich J, Jucker M, Holtzman DM et al (2013) Comment on \u201cApoE-directed therapeutics rapidly clear beta-amyloid and reverse deficits in AD mouse models\u201d. Science 340(6135):924\u201392f","journal-title":"Science"},{"issue":"8","key":"1665_CR89","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1186\/1750-1326-8-13","volume":"8","author":"JD Ulrich","year":"2013","unstructured":"Ulrich JD, Burchett JM, Restivo JL, Schuler DR, Verghese PB, Mahan TE, Landreth GE, Castellano JM et al (2013) In vivo measurement of apolipoprotein E from the brain interstitial fluid using microdialysis. Mol Neurodegener 8(8):13","journal-title":"Mol Neurodegener"},{"issue":"9","key":"1665_CR90","doi-asserted-by":"publisher","first-page":"1085","DOI":"10.1517\/14728222.2011.594043","volume":"15","author":"S Mandrekar-Colucci","year":"2011","unstructured":"Mandrekar-Colucci S, Landreth GE (2011) Nuclear receptors as therapeutic targets for Alzheimer\u2019s disease. Expert Opin Ther Targets 15(9):1085\u20131097","journal-title":"Expert Opin Ther Targets"},{"issue":"6135","key":"1665_CR91","doi-asserted-by":"publisher","first-page":"924-e","DOI":"10.1126\/science.1233937","volume":"340","author":"I Tesseur","year":"2013","unstructured":"Tesseur I et al (2013) Comment on \u201cApoE-directed therapeutics rapidly clear beta-amyloid and reverse deficits in AD mouse models\u201d. Science 340(6135):924-e","journal-title":"Science"},{"issue":"6135","key":"1665_CR92","doi-asserted-by":"publisher","first-page":"924","DOI":"10.1126\/science.1235809","volume":"340","author":"NF Fitz","year":"2013","unstructured":"Fitz NF, Cronican AA, Lefterov I, Koldamova R (2013) Comment on \u201cApoE-directed therapeutics rapidly clear beta-amyloid and reverse deficits in AD mouse models\u201d. Science 340(6135):924\u201392c","journal-title":"Science"},{"key":"1665_CR93","doi-asserted-by":"publisher","first-page":"33176","DOI":"10.1038\/srep33176","volume":"6","author":"MT Huuskonen","year":"2016","unstructured":"Huuskonen MT et al (2016) Bexarotene targets autophagy and is protective against thromboembolic stroke in aged mice with tauopathy. Sci Rep 6:33176","journal-title":"Sci Rep"},{"issue":"419","key":"1665_CR94","doi-asserted-by":"publisher","first-page":"eaal2332","DOI":"10.1126\/scitranslmed.aal2332","volume":"9","author":"AS Dickey","year":"2017","unstructured":"Dickey AS, Sanchez DN, Arreola M, Sampat KR, Fan W, Arbez N, Akimov S, van Kanegan MJ et al (2017) PPARdelta activation by bexarotene promotes neuroprotection by restoring bioenergetic and quality control homeostasis. Sci Transl Med 9(419):eaal2332","journal-title":"Sci Transl Med"},{"key":"1665_CR95","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1186\/s12974-014-0229-9","volume":"12","author":"T Malm","year":"2015","unstructured":"Malm T, Mariani M, Donovan LJ, Neilson L, Landreth GE (2015) Activation of the nuclear receptor PPARdelta is neuroprotective in a transgenic mouse model of Alzheimer\u2019s disease through inhibition of inflammation. J Neuroinflammation 12:7","journal-title":"J Neuroinflammation"},{"issue":"48","key":"1665_CR96","doi-asserted-by":"publisher","first-page":"17321","DOI":"10.1523\/JNEUROSCI.1569-12.2012","volume":"32","author":"M Yamanaka","year":"2012","unstructured":"Yamanaka M, Ishikawa T, Griep A, Axt D, Kummer MP, Heneka MT (2012) PPARgamma\/RXRalpha-induced and CD36-mediated microglial amyloid-beta phagocytosis results in cognitive improvement in amyloid precursor protein\/presenilin 1 mice. J Neurosci 32(48):17321\u201317331","journal-title":"J Neurosci"},{"issue":"30","key":"1665_CR97","doi-asserted-by":"publisher","first-page":"10117","DOI":"10.1523\/JNEUROSCI.5268-11.2012","volume":"32","author":"S Mandrekar-Colucci","year":"2012","unstructured":"Mandrekar-Colucci S, Karlo JC, Landreth GE (2012) Mechanisms underlying the rapid peroxisome proliferator-activated receptor-gamma-mediated amyloid clearance and reversal of cognitive deficits in a murine model of Alzheimer\u2019s disease. J Neurosci 32(30):10117\u201310128","journal-title":"J Neurosci"}],"container-title":["Molecular Neurobiology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12035-019-01665-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s12035-019-01665-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12035-019-01665-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,6,14]],"date-time":"2020-06-14T23:07:17Z","timestamp":1592176037000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s12035-019-01665-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,6,16]]},"references-count":97,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2019,12]]}},"alternative-id":["1665"],"URL":"https:\/\/doi.org\/10.1007\/s12035-019-01665-y","relation":{},"ISSN":["0893-7648","1559-1182"],"issn-type":[{"value":"0893-7648","type":"print"},{"value":"1559-1182","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,6,16]]},"assertion":[{"value":"13 March 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 May 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 June 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with Ethical Standards"}},{"value":"Human subject research at the New York Stem Cell Foundation was performed in accordance with applicable federal and state regulations, as well as with guidelines established by the National Institutes of Health (NIH), National Academy of Sciences (NAS), and International Society for Stem Cell Research (ISSCR). It was also fully compliant with standards outlined in the Health Insurance Portability and Accountability Act (HIPAA) and in the Office for Human Research Protections (OHRP) recommendations.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics Approval and Consent to Participate"}},{"value":"All authors declare their consent for publication of this manuscript.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for Publication"}},{"value":"The authors declare that they have no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing Interests"}}]}}